ATE255893T1 - Antikachektische zusammensetzung - Google Patents

Antikachektische zusammensetzung

Info

Publication number
ATE255893T1
ATE255893T1 AT97914591T AT97914591T ATE255893T1 AT E255893 T1 ATE255893 T1 AT E255893T1 AT 97914591 T AT97914591 T AT 97914591T AT 97914591 T AT97914591 T AT 97914591T AT E255893 T1 ATE255893 T1 AT E255893T1
Authority
AT
Austria
Prior art keywords
pct
bond
substituted
ring
group
Prior art date
Application number
AT97914591T
Other languages
English (en)
Inventor
Yu Momose
Etsuya Matsutani
Takashi Sohda
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE255893T1 publication Critical patent/ATE255893T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT97914591T 1996-04-04 1997-04-03 Antikachektische zusammensetzung ATE255893T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8284596 1996-04-04
JP9027957A JPH09323930A (ja) 1996-04-04 1997-02-12 悪液質の予防・治療剤
PCT/JP1997/001148 WO1997037656A1 (en) 1996-04-04 1997-04-03 Anticachectic composition

Publications (1)

Publication Number Publication Date
ATE255893T1 true ATE255893T1 (de) 2003-12-15

Family

ID=26365962

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97914591T ATE255893T1 (de) 1996-04-04 1997-04-03 Antikachektische zusammensetzung

Country Status (7)

Country Link
US (2) US6110948A (de)
EP (1) EP0893995B1 (de)
JP (1) JPH09323930A (de)
AT (1) ATE255893T1 (de)
AU (1) AU2177997A (de)
DE (1) DE69726716T2 (de)
WO (1) WO1997037656A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4408450B2 (ja) * 1994-07-01 2010-02-03 ウェルスタット セラピューティクス コーポレイション 全身性炎症および炎症性肝炎の処置のためのピリミジンヌクレオチド前駆体
WO1999025346A1 (en) 1997-11-19 1999-05-27 Takeda Chemical Industries, Ltd. Novel apoptosis inhibitors
EP0977753A1 (de) * 1997-12-02 2000-02-09 Dr. Reddy's Research Foundation Azolidinedione-derivate zur bekämpfung von diabetes, dislipämie und hypertonie
NZ333399A (en) * 1997-12-24 2000-05-26 Sankyo Co Cyclooxygenase-2 inhibitors (COX-2) for the prevention and treatment of tumors, cachexia and tumor-metastasis
US6897019B1 (en) * 1998-04-17 2005-05-24 Tufts College Methods for treating and preventing insulin resistance and related disorders
US7105552B2 (en) 1998-05-08 2006-09-12 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
US7407978B2 (en) * 1999-04-06 2008-08-05 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
TWI249401B (en) 1999-04-14 2006-02-21 Takeda Chemical Industries Ltd Agent for improving ketosis
US20030087942A1 (en) * 2001-08-31 2003-05-08 Washington University Method for the treatment and prevention of cachexia
US20080114055A1 (en) * 2006-11-10 2008-05-15 Zoltan Laboratories Llc Thioxanthone Compounds to Reverse Weight Loss
US20080207738A1 (en) * 2007-02-28 2008-08-28 Cancure Laboratories, Llc Drug combinations to treat drug resistant tumors
CA2688570A1 (en) * 2007-05-31 2008-12-04 F.P.L. Pharma Inc. Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof
MX2010000465A (es) * 2007-07-12 2010-08-30 Tragara Pharmaceuticals Inc Metodos y composiciones para el tratamiento de cancer, tumores y alteraciones relacionadas con tumores.
IL294709B2 (en) * 2020-01-13 2023-07-01 Astromedical Biotechnology Ltd Use of ketamine in the treatment of cachexia

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
TW268952B (de) * 1993-02-26 1996-01-21 Takeda Pharm Industry Co Ltd
GB9308487D0 (en) * 1993-04-23 1993-06-09 Smithkline Beecham Plc Novel compounds
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
JP3029768B2 (ja) * 1994-04-18 2000-04-04 三共株式会社 悪液質改善剤
WO1996004909A1 (en) * 1994-08-12 1996-02-22 Takeda Chemical Industries, Ltd. Use of quinone and hydroquinone derivatives for the teatment of cachexia
TW403748B (en) * 1994-11-02 2000-09-01 Takeda Chemical Industries Ltd An oxazolidinedione derivative, its production and a pharmaceutical composition for lowering blood sugar and lipid in blood comprising the same

Also Published As

Publication number Publication date
DE69726716D1 (de) 2004-01-22
AU2177997A (en) 1997-10-29
EP0893995B1 (de) 2003-12-10
US6110948A (en) 2000-08-29
JPH09323930A (ja) 1997-12-16
DE69726716T2 (de) 2004-10-07
US6365607B1 (en) 2002-04-02
WO1997037656A1 (en) 1997-10-16
EP0893995A1 (de) 1999-02-03

Similar Documents

Publication Publication Date Title
DE69726716D1 (de) Antikachektische zusammensetzung
TR200103185T2 (tr) MEK enzimleri inhibitörleri olarak kinolin türevleri.
NZ507735A (en) Indole derivatives useful for treating malignant and other diseases caused by pathological cell proliferation
PL348769A1 (en) 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
GB9300194D0 (en) Piperazine derivatives
IL117875A0 (en) Pharmaceutical compositions for inhibiting th growth of cancers
WO1999009965A3 (en) Anti-inflammatory agent
DE69833797D1 (de) Substituierte 2-benzylamino-2-phenyl-acetamidverbindungen
NZ333798A (en) Arylcycloalkane carboxylic esters, their use for the treatment of urinary incontinence or irritable bowel syndrome, and method of manufacture.
ZM3785A1 (en) Bis-(4 aminopheny-l)-sulfones
NO990578L (no) Diesel-brennstoff inneholdende oksygenerte forbindelser
CA2247946A1 (en) Anticachectic composition
ES2011075A6 (es) Procedimiento de obtencion de nuevas 3-(2-haloalquil)-1, 4-oxatiinas y2- (2-haloalquil) -1,4-ditiinas utiles en el tratamiento de leucemia y otros tumores.
IE44180L (en) Azaprostaglandins.
PL322069A1 (en) Arginin analoques exhibiting inhibiting activity in respect to synthase no
ZA957449B (en) Bicyclic carboxamides
NZ513724A (en) Anticonvulsant derivatives useful in treating essential tremor
NO970079D0 (no) Pyrido£3,2,1-i,j|£3,1|benzoksazinderivater
ES2017032A6 (es) Procedimiento para la obtencion de 4,5-dihidro-3(2h)-piridazinonas.
MX9709468A (es) Composiciones farmaceuticas para minimizar la perdida osea.
GR3006582T3 (de)
DE69511689D1 (de) Phosphonyldipeptide zur bekämpfung von kardiovasvakuläre erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties